Delivery Order SPE2DB22D9309-SPE2DB24FAE72

Award Date 3/19/24
Potential Completion Date 3/20/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,877.50 firm fixed-price delivery order is for the supply of SURGILUBE LUBRICANT 5GM, a medical product, with a completion date of December 31, 2024. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
The Defense Logistics Agency, an agency of the Department of Defense, awarded a firm fixed price delivery order valued at approximately $19,830 to DMS Pharmaceutical Group Inc. for SURGILUBE lubricant. The single item delivery order is for 3 grams of the lubricant and will be fulfilled by DMS Pharmaceutical Group from their facility located in Park Ridge, Illinois. Performance is required between July 31, 2023 and August 1, 2023. No subcontractors or set aside designations were identified. The...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $80,120 to DMS Pharmaceutical Group Inc. to supply Surgilube lubricant. The order is for 5 grams of lubricant and will be delivered to a location in Park Ridge, Illinois by July 31, 2023. The DLA manages the Department of Defense's global supply chain and distribution network, procuring medical supplies and pharmaceuticals to support military treatment facilities and readiness worldwide. No subcontractors or set...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifty thousand two hundred twenty-four dollars ($150,224) to DMS Pharmaceutical Group Inc. to provide five hundred (500) grams of Surgilube lubricant. The place of performance is Park Ridge, Illinois and the period of performance is August 22, 2023 through August 23, 2023. The Defense Logistics Agency supports America's armed forces by delivering critical supplies such as medical materials. This delivery...
DMS Pharmaceutical Group Inc. was awarded a delivery order against an unidentified contract vehicle by the Defense Logistics Agency (DLA) on November 30, 2022. The order is for SURGILUBE LUBRICANT in 5gm units with a potential value of $225. Performance will occur in Park Ridge, Illinois by December 1, 2022 under firm fixed price terms. No set-aside provision was applied to this order. As the DLA manages the global supply chain for the Department of Defense, this order is likely supporting...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $19,830 to DMS Pharmaceutical Group Inc. to provide SURGILUBE LUBRICANT 3GM. The single day contract has a period of performance from August 15-16, 2023 to deliver the medical lubricant to a location in Park Ridge, Illinois. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports America's armed forces by providing supplies in areas including food, clothing,...
The Defense Logistics Agency Troop Support Medical (DLA), a component of the U.S. Department of Defense, awarded a firm fixed price delivery order valued at one hundred dollars and fifteen cents ($100.15) to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for one hundred twenty point four nine grams (120.49gm) of Surgilube lubricant to be delivered between July 6 and July 7, 2023. DLA manages the medical supply chain for the DoD and stockpiles critical wartime medical...
The Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, awarded a firm fixed price delivery order valued at $37,550 to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4561607365 units of Surgilube Lubricant in 5-gram packages to be delivered to the prime contractor's facility by July 21, 2023. No subcontractors or set aside designations were identified. The DLA manages the global supply chain for the DoD, procuring goods and services to...
DMS Pharmaceutical Group Inc. was awarded a thirty-seven dollar firm fixed price delivery order for SURGILUBE lubricant under an unidentified contract vehicle with the Defense Logistics Agency. The order is for five grams of the lubricant and is to be completed by April 5, 2023. Performance will take place in Park Ridge, Illinois. No set-aside provision was applied to this order for the medical supply. The Defense Logistics Agency supports military treatment facilities and contingency operations...
DMS Pharmaceutical Group Inc. was awarded a thirty-seven dollar firm fixed price delivery order for SURGILUBE lubricant under an unidentified contract vehicle with the Defense Logistics Agency. The delivery order, awarded on August 8, 2023, has a period of performance through August 9, 2023 and involves providing 5gm units of SURGILUBE lubricant to the Defense Logistics Agency distribution center located in Park Ridge, Illinois. No set-aside designation was applied to this delivery order award.
  • SPE2DB22D9309
    Indefinite Delivery Contract
  • SPE2DB22D9309-SPE2DB24FAE72
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, for the provision of SURGILUBE LUBRICANT 120.49GM. The contract, identified as SPE2DB22D9309|SPE2DB24FAE72, has a ceiling value of $10,086.00 and a performance period through March 20, 2024. This delivery order contract is part of a larger indefinite delivery vehicle (IDV), contract 4600082013 under the SPE2DB program, which has a maximum value of $4,999,999 and enables DLA to issue fixed-price orders for a broad range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract has no set-aside designation.

Generated 6/18/24, 2:21 PM